beyond spring pharma stock
BYSI stock are taking off on Wednesday following an important update regarding the firms lung cancer treatment. BeyondSpring is a global clinical-stage bio-pharmaceutical company developing innovative immuno-oncology cancer therapies with a robust pipeline from internal development and.
Pharmaceutical Sector Fails To Spring Higher Amid Lackluster April Performance Nyse Pfe Seeking Alpha
BYSI stock news and headlines to help you in your trading and investing decisions.
. Is a clinical-stage global biopharmaceutical company. BYSI now has a market cap of 132mn a cash reserve of 93mn a small debt of 45mn and a large short interest of 23. Get the latest BeyondSpring Inc.
The company currently falls under Micro-Cap category with current market. They recently received or are about to receive. Beyondspring is listed under Pharmaceutical Products category by Fama And French industry classification.
Shares of BeyondSpring NASDAQ. The Company is focused on developing cancer therapies to improve clinical outcomes for patients. BeyondSpring Pharmaceuticals Inc NASDAQBYSI shared the final intention-to-treat ITT dataset from its DUBLIN-3 Phase 3 trial of plinabulin.
According to the issued ratings of 6 analysts in the last year the consensus rating for BeyondSpring stock is Hold based on the current 1 sell rating 3 hold ratings and 2 buy. Shares of BeyondSpring BYSI -362 soared on Wednesday after the pharmaceutical company released promising clinical trial results for its investigational lung. 20 2021 0222 PM.
Contact Us Beyondspring
Circling Back On Beyondspring Bysi Stock Seeking Alpha
Stock Overview Beyondspring
Pin Em Png
Circling Back On Beyondspring Bysi Stock Seeking Alpha
Beyondspring Nasdaqcm Bysi Share Price News Analysis Simply Wall St
Watercolor Floral Curtain Panel Autumn Blooms Giant Bright Etsy Floral Curtains Panel Curtains Custom Curtains
Beyondspring Inc Bysi Stock Price News Quote History Yahoo Finance
Stock Overview Beyondspring
Beyondspring Stock Nasdaq Bysi Quotes And News Summary Benzinga
Beyondspring Analyst Sees Little Trouble In Big China Nasdaq
2012 0074 Annual Screenings Handout Indd Health Screening Health Chart Patient Education
Beyondspring Would Be A Great Buy Except For The Perennial Need For Cash And Ensuing Dilution Nasdaq Bysi Seeking Alpha
A Century Of Cherry Blossom Watches
Beyondspring S Plinabulin Upcoming Pdufa And Positioning In The Cin Space Nasdaq Bysi Seeking Alpha
Pipeline Beyondspring
This 20 Billion Hedge Fund Is Gobbling Up Teva Pharmaceutical Industries Limited The Motley Fool Hedge Fund Manager Hedge Fund Investing The Motley Fool
Beyondspring Inc Bysi Stock Price News Quote History Yahoo Finance
Financials Filings Beyondspring